-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Lisata Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2016 to 2023.
- Lisata Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 8.31M shares, a 3.58% increase year-over-year.
- Lisata Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8.07M shares, a 55.8% increase from 2022.
- Lisata Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5.18M shares, a 40.5% increase from 2021.
- Lisata Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 3.69M shares, a 76.1% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)